Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Amy Xia

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Therapeutic Innovation & Regulatory Science|September 21, 2018
Statistical Evaluation of Drug Safety DataH Amy Xia, Qi Jiang
Journal of Biopharmaceutical Statistics|January 22, 2013
The practice of pre-marketing safety assessment in drug developmentChristy Chuang-Stein, H Amy Xia
Journal of Biopharmaceutical Statistics|August 12, 2011
Bayesian hierarchical modeling for detecting safety signals in clinical trialsH Amy Xia, Haijun Ma, Bradley P Carlin
Pharmaceutics|December 5, 2013
Safety monitoring in clinical trialsBin Yao, Li Zhu, Qi Jiang, et al.
Biometrics|September 30, 2011
Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetesJoseph G Ibrahim, Ming-Hui Chen, H Amy Xia, et al.
Frontiers in Oncology|February 3, 2023
Landmark mediation survival analysis using longitudinal surrogateJie Zhou, Xun Jiang, H Amy Xia, et al.
Biostatistics (Oxford, England)|May 13, 2021
Bayesian adaptive design for concurrent trials involving biologically related diseasesMatthew A Psioda, H Amy Xia, Xun Jiang, et al.
Statistics in Medicine|December 18, 2013
Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development programMing-Hui Chen, Joseph G Ibrahim, H Amy Xia, et al.
Journal of Biopharmaceutical Statistics|March 20, 2025
Improving power in adaptive expansion of biomarker populations in phase 3 clinical trialsGuoqing Diao, Xun Jiang, Donglin Zeng, et al.
Cancer Metastasis Reviews|January 30, 2026
PD-L1 subpopulations of metastatic urothelial carcinoma demonstrate heterogeneity to chemotherapy: an integrated analysis of digitized trial resultsJie Zhou, Xun Jiang, Qing Liu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Therapeutic Innovation & Regulatory Science|September 21, 2018
Statistical Evaluation of Drug Safety DataH Amy Xia, Qi Jiang
Journal of Biopharmaceutical Statistics|January 22, 2013
The practice of pre-marketing safety assessment in drug developmentChristy Chuang-Stein, H Amy Xia
Journal of Biopharmaceutical Statistics|August 12, 2011
Bayesian hierarchical modeling for detecting safety signals in clinical trialsH Amy Xia, Haijun Ma, Bradley P Carlin
Pharmaceutics|December 5, 2013
Safety monitoring in clinical trialsBin Yao, Li Zhu, Qi Jiang, et al.
Biometrics|September 30, 2011
Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetesJoseph G Ibrahim, Ming-Hui Chen, H Amy Xia, et al.
Frontiers in Oncology|February 3, 2023
Landmark mediation survival analysis using longitudinal surrogateJie Zhou, Xun Jiang, H Amy Xia, et al.
Biostatistics (Oxford, England)|May 13, 2021
Bayesian adaptive design for concurrent trials involving biologically related diseasesMatthew A Psioda, H Amy Xia, Xun Jiang, et al.
Statistics in Medicine|December 18, 2013
Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development programMing-Hui Chen, Joseph G Ibrahim, H Amy Xia, et al.
Journal of Biopharmaceutical Statistics|March 20, 2025
Improving power in adaptive expansion of biomarker populations in phase 3 clinical trialsGuoqing Diao, Xun Jiang, Donglin Zeng, et al.
Cancer Metastasis Reviews|January 30, 2026
PD-L1 subpopulations of metastatic urothelial carcinoma demonstrate heterogeneity to chemotherapy: an integrated analysis of digitized trial resultsJie Zhou, Xun Jiang, Qing Liu, et al.
Pageof 3